| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Patterson Chad | Chief Commercial Officer | C/O IRHYTHM TECHNOLOGIES, INC, 699 8TH ST #600, SAN FRANCISCO | /s/ Marc Rosenbaum, attorney-in-fact | 03 Jun 2025 | 0001850152 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IRTC | Common Stock | Award | $21,295 | +298 | +0.6% | $71.46 | 50,228 | 30 May 2025 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Mr. Patterson is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period December 1, 2024 through May 31, 2025. This transaction is exempt from Section 16(b) under Rule 16b-3. |